According to the latest Hong Kong Stock Exchange filings, Lazard Asset Management LLC acquired an additional 235,200 shares of SINOPHARM (01099) on October 2nd at a price of HK$18.61 per share, representing a total transaction value of approximately HK$4.3771 million. Following this acquisition, the investment firm now holds approximately 134 million shares, representing a 10.01% ownership stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.